Synthetic food dyes are added to 1 in 5 packaged foods and drinks sold by top U.S. food manufacturers, a new study says.

The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending a years-long wait for the much-hyped medication.

Viking Therapeutics stock remains under pressure, but analysts said Wednesday the company's strategy for its Phase 3 studies could pay off.

Novo Nordisk is seen as having fallen behind in the race for new obesity drugs. It argues it is playing the long game.

Weight-loss surgery seems to lower the risk of colorectal cancer by changing where bile acids enter the small intestine, ...

Weight-loss drugs look poised to have a worrying effect on UK supermarkets as total grocery sales volumes fall. Market ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

A new study is revealing that weight loss surgery may be the better option for sustained weight loss over weight loss medications.

Academics at King's College London and the University of East Anglia have released guidance for GPs on how to manage patients ...

It’s scary to think that we may have been using a surrogate — BMI — that may not have been all that accurate over the years," ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.